Amyotrophic lateral sclerosis.

Area of Science:

• Neurology
• Genetics
• Molecular Biology

Background:

• Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive muscle paralysis due to motor neuron loss.
• Current treatments for ALS offer limited efficacy, and the disease is primarily sporadic.
• Historically, research focused on Cu,Zn superoxide dismutase (Cu,ZnSOD) mutations, implicated in a subset of familial and sporadic ALS cases.

Purpose of the Study:

• To provide a comprehensive overview of the clinical aspects of ALS.
• To elucidate the genetic and molecular mechanisms underlying ALS pathogenesis.
• To discuss the role of Cu,ZnSOD mutations and highlight recent findings on TDP-43 and FUS/TLS mutations.

Main Methods:

• Review of clinical presentations of ALS.
• Analysis of genetic factors contributing to ALS.
• Examination of molecular pathways involved in motor neuron degeneration.

Main Results:

• Mutations in Cu,ZnSOD are associated with a portion of ALS cases.
• Mutations in TDP-43 and FUS/TLS, genes involved in DNA/RNA synthesis, are identified as key genetic drivers in a significant number of ALS cases.
• These findings expand the understanding of ALS etiology beyond Cu,ZnSOD.

Conclusions:

• Understanding the genetic basis of ALS, including mutations in Cu,ZnSOD, TDP-43, and FUS/TLS, is crucial for developing effective therapies.
• Recent discoveries regarding TDP-43 and FUS/TLS mutations represent a significant advancement in ALS research.
• Further investigation into these genetic factors may pave the way for novel therapeutic strategies for ALS.